Cell Culture Technology– category –
-
Lonza Reports Strong Q1 2026 Performance, Driven by Robust CDMO Growth and Strategic Transformation into Pure-Play Biopharma Partner
Lonza Switzerland Overview Lonza delivered strong Q1 2026 performance across its Contract Development and Manufacturing Organization (CDMO) business, aligning with full-year expectations despite macroeconomic challenges. The company secu... -
Advanced 3D Bioprinting Techniques Drive Progress in Organoid and Tissue Development for Regenerative Medicine and Drug Discovery
News-Medical.Net UK Overview This technical article highlights advancements in 3D bioprinting for creating sophisticated organoid and tissue models, emphasizing their potential for cell therapy, personalized diagnostics, and drug discove... -
Pharmaceutical Membrane Filtration Market: Size, Share, and Growth Forecast to 2034 – A Straits Research Overview
Straits Research Germany Overview This article provides an overview of a market research report published by Straits Research, detailing the pharmaceutical membrane filtration market's current status and projected growth to 2034. The rep... -
Form Bio Launches FormManufacturing: An AI-Driven End-to-End Platform for Genetic Medicine Design and Manufacturing Optimization
Morningstar USA Overview Form Bio has introduced FormManufacturing™, an AI-driven, end-to-end platform for predicting, optimizing, and monitoring manufacturability of genetic medicines, debuting with an AAV-focused offering. Integrating ... -
SuperMeat Secures $6M in Funding, Accelerating Commercialization of Cultivated Chicken for Swiss Market Entry
PPTI News - Protein Production Technology International UK Overview SuperMeat has raised $6 million in Series A-4 funding, part of a targeted $10 million round, to accelerate the commercialization of its cultivated chicken technology and... -
ProBio and Curocell Achieve BLA Approval for Next-Gen CD19-Targeted CAR-T Therapy, Initiating Commercial Production in South Korea
ProBio CDMO South Korea Overview ProBio CDMO and Curocell have secured Biologics License Application (BLA) approval for anbalcabtagene autoleucel (Anbal-cel; CRC01), their next-generation CD19-targeted CAR-T cell therapy for relapsed or ... -
AIST Develops Novel Culture Media Analysis Technology Using Multifluorescent Polymers and AI, Revolutionizing Biomanufacturing Quality Control
AFPBB News Japan Overview Japan's National Institute of Advanced Industrial Science and Technology (AIST) has developed a novel analytical technology to assess the quality of cell culture media and supplements, critical for biomanufactur... -
Terumo BCT and Steminent Partner to Automate Mesenchymal Stem Cell Manufacturing for Late-Stage Clinical Commercialization
Terumo Blood and Cell Technologies Taiwan Overview Terumo Blood and Cell Technologies (Terumo BCT) and Taipei-based Steminent Biotherapeutics Inc. have announced a strategic collaboration to accelerate late-stage manufacturing readiness ... -
Ajinomoto Develops Novel Culture Medium Supplement to Boost Gene Therapy Drug Productivity, Accelerating Biomanufacturing Efficiency
味の素株式会社 IRニュース Japan Overview Ajinomoto Group, in collaboration with its U.S. subsidiary Forge Biologics (acquired in 2023 for ~¥82.8 billion), has developed a novel culture medium supplement designed to significantly enhance ... -
Helios Advances ARDS Therapy Approval, Bolstering Regenerative Medicine CDMO with New Kobe Manufacturing Hub
FISCO Japan Overview Helios is progressing towards regulatory approval for its Acute Respiratory Distress Syndrome (ARDS) therapeutic, HLCM051, while simultaneously enhancing its Contract Development and Manufacturing Organization (CDMO)...
